Androgen deficiency is important in the pathophysiology of atrial fibrillation. Androgen regulates cardiac electrophysiology and calcium (Ca 2ϩ ) homeostasis. The purpose of this study is to evaluate whether androgen receptor knockout (ARKO) can modulate atrial electrophysiology and arrhythmogenesis with modulation of Ca 2ϩ homeostasis proteins. We used conventional microelectrodes to study the action potential (AP) in left atrium (LA) tissues prepared from wild-type (WT) and ARKO mice (aged 6 -10 months) before and after the administration of isoproterenol, hypocalcemic/hypercalcemic solutions, and ouabain. Echocardiography and Western blots were used to evaluate the cardiac function and expression levels of ionic channel proteins in WT and ARKO LAs. ARKO LAs had larger LA diameter with decreased LA fractional shortening than did WT LAs. In the current study, we found that ARKO LAs had a lower negative resting membrane potential and a greater 90% AP duration (APD) than did WT LAs. A trial fibrillation (AF) is the most common cardiac arrhythmia seen in clinical practice and can induce cardiac dysfunction and stroke (1, 2). Aging is associated with a decrease in sex hormones (3) and increases the incidence of AF in both males and females. However, the age-specific prevalence of AF is higher in men than in women (4). Lower T levels can enhance the occurrence of AF (5). In contrast, the Framingham Heart Study found that meno-
Androgen deficiency is important in the pathophysiology of atrial fibrillation. Androgen regulates cardiac electrophysiology and calcium (Ca 2ϩ ) homeostasis. The purpose of this study is to evaluate whether androgen receptor knockout (ARKO) can modulate atrial electrophysiology and arrhythmogenesis with modulation of Ca 2ϩ homeostasis proteins. We used conventional microelectrodes to study the action potential (AP) in left atrium (LA) tissues prepared from wild-type (WT) and ARKO mice (aged 6 -10 months) before and after the administration of isoproterenol, hypocalcemic/hypercalcemic solutions, and ouabain. Echocardiography and Western blots were used to evaluate the cardiac function and expression levels of ionic channel proteins in WT and ARKO LAs. ARKO LAs had larger LA diameter with decreased LA fractional shortening than did WT LAs. In the current study, we found that ARKO LAs had a lower negative resting membrane potential and a greater 90% AP duration (APD) than did WT LAs. Isoproterenol increased the incidence and amplitude of delayed afterdepolarizations (DADs) in ARKO LAs but not in WT LAs. Hypocalcemic solutions prolonged APD in WT and ARKO LAs but increased DAD amplitude only in ARKO LAs. Hypercalcemic solutions shortened APD in ARKO LAs but not in WT LAs. Ouabain increased DAD amplitude in ARKO LAs but not in WT LAs. ARKO A trial fibrillation (AF) is the most common cardiac arrhythmia seen in clinical practice and can induce cardiac dysfunction and stroke (1, 2) . Aging is associated with a decrease in sex hormones (3) and increases the incidence of AF in both males and females. However, the age-specific prevalence of AF is higher in men than in women (4). Lower T levels can enhance the occurrence of AF (5 pause may not be an independent risk factor for AF (6) . Therefore, T deficiency plays a more important role than does estrogen deficiency in the pathogenesis of AF. Moreover, androgen deprivation therapy increases the risk of AF in the management of men with prostate cancer (7) . T is the most important endogenous androgen and exerts its action over the amplification, direct, and diversification pathways. T and its major metabolite, dihydrotestosterone, both activate the androgen receptor (AR). In addition, a small fraction of testosterone is converted to estradiol and diversifies androgen action through estrogen receptors (8) . ARs are also present in cardiac myocytes in a context that permits androgens to modulate the cardiac phenotype and produce hypertrophy by direct, receptorspecific mechanisms (9) . T at physiological levels augmented the contractile response to adrenoceptor stimulation, which occurs through the modulation of cardiac calcium (Ca 2ϩ )-handling proteins (10) . Androgen deficiency led to a reduction in the density of I Kur and Kv1.5 in mouse ventricles (11) . Therefore, androgen may be associated with cardiac structuring and electrical remodeling. Castration has been shown to increase atrial arrhythmogenecity, and the administration of T attenuated this increased atrial vulnerability (12) . However, it is not clear whether these findings were caused by the activation of AR. Mice containing an AR knockout (ARKO) may provide a way to validate the role of the AR in atrial electrophysiology (13) . In ARKO male mice, testicular androgen production is severely impaired, which leads to a reduction in serum gonadal androgen levels but normal serum estrogen levels (14) . The left atrium (LA) is the main AF substrate for reentry (15, 16) . High-frequency sources in the LA act as triggers and/or drivers for AF (17, 18 
Materials and Methods

Animal preparations
The experimental protocols in this study were approved by the institutional Guide for the Care and Use of Laboratory Animals. Adult male mice with a deleted AR and their wild-type (WT) male littermates were used in this study. Female mice carrying one copy of floxed AR (with exon 2 of the AR placed between 2 lox sites) and male mice carrying the Cre-recombinase gene driven by the promoter ␤-actin were both generously provided by Dr Chawnshang Chang (University of Rochester, Rochester, New York) and were used to generate male ARKO mice and their WT littermates based on a previous publication (20) . Animals were housed in the Animal Center of Taipei Medical University with a controlled light condition (12 hour light, 12 hour dark cycle with lights on at 7:00 AM), temperature (22 Ϯ 2°C), humidity (50%-60%) and corn-cob bedding. All animals in groups of 4 in a cage had free access to water and food (Laboratory Rodent Diet 5001, Lab Diet, St Louis, Missouri).
Mice were genotyped based on a published protocol (20) . In brief, primer select (5Ј-GTTGATACCTTAACCTCTGC-3Ј) and primers 2-9 (5Ј-CCTACATGTACTGTGAGAGG-3Ј) were used to amplify the DNA fragments of floxed AR (ϳ800 bp), WT AR (580 bp), and AR with deletion of exon 2 (ARKO, 238 bp) during PCR amplification of extracted DNA from the tail (0.5 cm) of each mouse. The myocardial DNA extraction from WT and ARKO mice was used to confirm the ARKO allele of 238 bp and the WT allele of 580 bp ( Figure 1A ).
The T concentration was measured from the myocardium and the serum. Briefly, myocardial tissues were homogenized in icecold lysis buffer containing (in millimoles) 20 Tris (pH 7.5), 150 NaCl, 1 EDTA, 1 EGTA, 2 Na 3 VO 4 , 10 NaF, 1% Triton X-100, and protease inhibitor cocktail (Sigma-Aldrich, St Louis, Missouri). The extracts were centrifuged at 13 000 rpm for 10 minutes, and supernatants were harvested for T concentration determination. T from the myocardium or serum and serum estradiol were assayed using the ADVIA Centaur testosterone and estradiol systems (ADVIA Centaur assay; Bayer, Newbury, United Kingdom) (21) .
Echocardiographic analysis
Transthoracic echocardiography was performed using a 30-MHz imaging transducer (Vevo 770 Visual Sonic machine; Toronto, Canada). Mice from each group were anesthetized by a peritoneal injection of 20 mg/kg pentobarbital. The LA was visualized in a parasternal long-axis view in the plane of the aortic root. The LA diameter was measured during the ventricular systole at its maximal dimension. The LA total emptying fraction (LATEF), LA fractional shortening (FS; LAFS), interventricular septum (IVS), left ventricular (LV) end-diastolic dimension, LV end-systolic dimension, LV posterior wall thickness, LVFS, LV mass, relative wall thickness, and LV ejection fraction (LVEF) were measured using leading-edge techniques of the American Society of Echocardiography (22) .
Electrophysiological and pharmacological studies in mice LA preparations
WT and ARKO mice (36.3 Ϯ 2.3 vs 36.3 Ϯ 2.4 mg, aged 8 -10 mo) were anesthetized with an ip injection of sodium pentobarbital (100 mg/kg). A midline thoracotomy was performed, and the heart and lungs were removed. For dissection of the LA preparation, the LA was opened by an incision along the mitral valve annulus and extending from the coronary sinus to the septum in Tyrode's solution with a composition (in millimoles) of 137 NaCl, 4 KCl, 15 NaHCO 3 , 0.5 NaH 2 PO 4 , 0.5 MgCl 2 , 2.7 CaCl 2 , and 11 dextrose. The LAs (1 mm long and 0.4 mm wide) were then dissected and pinned with needles to the bottom of a tissue bath. The other end was connected to a Grass FT03C force transducer (Grass Instrument Co, Quincy, Massachusetts) with silk thread. The adventitia or epicardial side of the preparations faced upward. The tissue was superfused at a constant rate of 3 mL/min with Tyrode's solution, which was saturated with a 97% O 2 and 3% CO 2 gas mixture. The temperature remained constant at 37°C, and the preparations were allowed to equilibrate for 1 hour before the electrophysiological study.
Transmembrane action potentials (APs) of the LA were recorded by means of machine-pulled glass capillary microelectrodes filled with 3 M KCl, and tissue preparations were connected to a WPI model FD223 electrometer (World Precision Instruments, Sarasota, Florida) under a tension of 150 mg. Thus, the proarrhythmia seen at the baseline was stretch induced. Electrical and mechanical events were simultaneously displayed on a Gould 4072 oscilloscope and Gould TA11 recorder (Gould Instruments, Valley View, Ohio). Signals were recorded with DC coupling and a 10-kHz lowpass filter cutoff frequency using a data acquisition system. The electrical stimulus was provided by a Grass S88 stimulator through a Grass SIU5B stimulus isolation unit. Spontaneous activity was defined as the constant occurrence of spontaneous APs using no electrical stimuli. Early afterdepolarizations (EADs) were defined as interruption of the smooth contour of phase 2 or 3 of the APs (23) . Delayed afterdepolarizations (DADs) were defined as the presence of a spontaneous hump-shaped depolarization of the impulse after full repolarization had occurred (24) . EADs and DADs were selected from consistent deflections without abrupt changes in the resting membrane potential (RMP) or AP morphology (24, 25) . APs were elicited through a 4-Hz electrical stimulus before and after drug administration. The RMP was measured during the period between the last repolarization and onset of the subsequent AP. The AP amplitude (APA) was obtained from the RMP to the peak of the AP depolarization. The AP duration (APD) at repolarization extents of 90%, 50%, and 20% of the APA were measured and respectively designated APD 90 , APD 50 , and APD 20 . Similar to previous studies, different concentrations of isoproterenol (0 and 0.1 M), hypocalcemic (1 mM), and hypercalcemic (4 mM) solutions and ouabain (0 and 1 M) were superfused for at least 10 minutes to test their effects on the tissue preparations (26 -28) .
Western blot analysis of mice LAs
LA tissues from WT (n ϭ 7) and ARKO (n ϭ 7) mice were homogenized and sonicated in buffer containing 50 mM Tris (pH 7.4), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 20 mM NaF, 2 mM Na 3 VO 4 , and protease inhibitor cocktail (Sigma-Aldrich). Equal amounts of total protein were separated on 5% or 8% SDS- Figure 1 . Genotype screening, T measurements, and echocardiographic analysis of WT and ARKO mice. A, We amplified a 580-bp DNA fragment, which represents WT AR, and another of 238 bp, which represents the ARKO exon 2. B, T levels in the sera and heart were lower in ARKO (n ϭ 7) than in WT (n ϭ 7) mice. The estradiol levels were similar between the 2 groups. Values are given as mean Ϯ SEM. *, P Ͻ .05. C, Representative motion mode of LV wall and 2-dimensional echocardiographic image for measuring the LA area in the parasternal long-axis view in atrial diastole and systole in WT and ARKO mice. The upper panel is a representative image from WT mice. IVSd ϭ 1.21 mm, LVEF ϭ 79.7%, LATEF ϭ 35.4%, LAFS ϭ 25.4%. The lower panel is a representative image from ARKO mice. IVSd ϭ 0.85 mm, LVEF ϭ 68.4%, LATEF ϭ 13.24%, LAFS ϭ 12.9%. D, Bars indicate the average measurements from WT (n ϭ 6) and ARKO (n ϭ 6) mice. Values are given as mean Ϯ SEM. *, P Ͻ .05. AO, aorta; BW, body weight; HR, heart rate; IVSd, interventricular septum in diastole; RWT, relative wall thickness. tein-coupled receptor kinases-2 (GRK2) (both from Santa Cruz Biotechnology, Santa Cruz, California), Kir2.3, Kv7.1 (both from Millipore, Billerica, Massachusetts), Na ϩ /Ca 2ϩ exchanger (NCX) (Swant, Marly, Switzerland), Kir3.1 (GeneTex, Irvine, California), and secondary antibodies conjugated with horseradish peroxidase. Bound antibodies were detected with an enhanced chemiluminescence detection system (Santa Cruz Biotechnology) and analyzed with Image-Pro Plus software (Media Cybernetics, Silver Spring, Maryland). The targeted bands were normalized to cardiac ␣-sarcomeric actin (Sigma-Aldrich) as an internal control and then normalized to the value of WT LAs.
Statistical methods
All continuous variables are expressed as the mean Ϯ SEM. The baseline electrophysiological and echocardiographic characteristics of WT and ARKO mice were compared by 2-sample t tests assuming separate variance for each sample. Twoway repeated-measures ANOVA followed by the Holm-Sidak method was used to compare differences before and after drug administration to control for the overall type I error at 0.05 in the multiple comparison setting. Nominal variables were compared by a 2 analysis with the Yates correction or Fisher's exact test. Results with a P Ͻ .05 were considered significant.
Results
T measurement and echocardiographic analysis of WT and ARKO mice
ARKO mice had lower serum and myocardium T concentration but similar serum estradiol as compared with WT mice ( Figure 1B) . In addition, echocardiographic analysis showed that ARKO mice had a larger LA anteroposterior diameter, slower heart rate, decreased LATEF and LAFS, and lower LV mass/body weight and IVS in diastole than WT mice. However, WT and ARKO mice had similar body weight, LVFS, and LVEF ( Figure 1, C and D) . 
Effects of isoproterenol on LAs in WT and ARKO mice
Isoproterenol (0.1 M) prolonged the APD 90 (20.5 Ϯ 3.6 to 31.3 Ϯ 5.6 ms, P ϭ .037), APD 50 (6.3 Ϯ 0.6 to 9.9 Ϯ 1.0 ms, P ϭ .035), and APD 20 (2.9 Ϯ 0.5 to 4.8 Ϯ 0.3 ms, P ϭ .022) in 5 of 10 WT LAs (50%) but shortened the APD 90 (34.2 Ϯ 5.1 to 20.6 Ϯ 3.9 ms, P ϭ .019) and APD 50 (9.4 Ϯ 1.3 to 6.9 Ϯ 1.3 ms, P ϭ .039) in the other 5 WT 1 M) induced only EADs, DADs, and spontaneous activity in one WT LA (0% vs 10%, n ϭ 10, P ϭ 1). However, isoproterenol (0.1 M) significantly increased the incidence (60% vs 10%, n ϭ 10, P ϭ .019) and amplitude (1.9 Ϯ 0.2 vs 1.2 Ϯ 0.1 mV, t ϭ 3.293, P ϭ .002) of DADs in ARKO LAs. In the presence of isoproterenol (0.1 M), EADs were found in 3 of 10 ARKO LAs (30% vs 10%, P ϭ .576), and spontaneous activity was found in 2 ARKO LAs with EADs (20% vs 0%, P ϭ .456). In addition, isoproterenol induced atrial tachyarrhythmia, followed by spontaneous activity with EADs ( Figure 3B ). 
Effects of extracellular Ca
Protein expression levels in WT and ARKO mice
As shown in Figure 6 , ARKO LAs had lower levels of Kir2.1, Kir3.1, and Kv7.1 than WT LAs. ARKO and WT LAs had similar levels of Kv1.4, Kv1.5, Kv11.1, and Kir2.3. In addition, as shown in Figure 7 , ARKO LAs exhibited higher levels of NCX, CaMKII, PLB-Ser16, PLB-Thr17, and ratios of PLB-Ser16 to PLB and PLBThr17 to PLB than did WT LAs. ARKO LAs had similar levels of RyR, SERCA2a, and PLB but less Cav1.2 compared with WT LAs. Moreover, the protein expression of GRK2 was higher in ARKO LAs than in WT LAs.
Discussion
T dysregulation is significantly associated with cardiac electrophysiology and the genesis of AF. For the first time, this study demonstrates the roles of the AR in LA electrical characteristics. In ARKO LA, lengthening of the APD and less negative RMP might have been caused by the lower expression levels of Kir2.1 (coding for I K1 ), Kir3.1 (coding for I KAch ), and Kv7.1 (coding for I Ks ). However, the 3 K ϩ currents (I Kur , I to , and I Kr ) present in LAs were not different between ARKO and WT mice. Gonadectomy produced a substantial decrease in mRNA levels for the AR and the L-type calcium channel (LTCC) (29) . In the present study, we also observe lower protein expression of Cav1.2 in ARKO LAs, which may reduce the AP prolongation effect caused by the decreased expression of K ϩ channel proteins. Taken together, the less negative RMP and longer APDs in ARKO LAs suggested that ablation of the AR would change the atrial electrophysiology. Moreover, we found that ARKO mice had larger LA diameters and impaired LAFS, which would facilitate the genesis of atrial arrhythmia through structural remodeling and mechanoelectrical feedback. Adrenergic stimulation can affect the electrophysiological mechanisms of AF initiation and/or maintenance. In the present study, isoproterenol increases the amplitude of DADs to a greater extent in ARKO LAs than in WT LAs. These findings may result in higher arrhythmogenesis during enhanced sympathetic activity. Under ␤-adrenergic stimulation, T-induced nitric oxide release inhibited LTCC, which under such condition leads to shorter APDs (30, 31) . In our study, isoproterenol consistently prolonged APDs in ARKO LAs but prolonged or shortened APDs in WT LAs. These findings suggested different adrenergic responses between ARKO and WT LAs.
Transgenic CaMKII-overexpressing mice had an increased incidence of proarrhythmogenic events in vitro (32) . We found that the protein expression of CaMKII was higher in ARKO LAs than in WT LAs. These findings suggest that increased CaMKII in ARKO LAs was arrhythmogenic; therefore, CaMKII-dependent arrhythmias were additionally enhanced after activation through ␤-adrenergic stimulation. In vitro assays showed that protein kinase A (PKA) exclusively catalyzed the phosphorylation of PLB-Ser16, whereas CaMKII gave exclusive phosphorylation of PLB-Thr17 (33) . In this study, the protein expression levels of both PLB-Ser16 and PLB-Thr17 were higher in ARKO LAs than in WT LAs, which implied higher activities of PKA and CaMKII in ARKO LAs. Hyperphosphorylation of RyR by CaMKII in vitro induced diastolic Ca 2ϩ leakage and resulted in afterdepolarizations (34) . Consistent with this, our findings suggest that CaMKII overexpression played a role in T deficiency-related proarrhythmia. In addition, the increased NCX expression in ARKO LAs might also cause DADs and triggered activity. Moreover, this study found an increase in GRK2 in ARKO LAs. GRK2 significantly regulates cardiac contractility and hypertrophy. T dysregulation may result in a decrease in ␤-adrenergic receptors with abnormal Ca 2ϩ homeostasis (29) . Gonadectomized male rats had a reduction in contractile performance and depressed cardiac myosin ATPase activity (35) . The elevated GRK2 level in ARKO LAs might result in ␤-adrenergic receptor dysfunction, which would contribute to the decreased LAFS in vivo detected by echocardiography, and the trivial response of contractility to isoproterenol in isolated LA preparations. In addition, the enhanced GRK2 expression in ARKO LAs might induce higher CaMKII activity through ␤-arrestin recruitment (36). However, there was similar baseline contractility in WT and ARKO isolated LAs, which might be caused by increased SERCA2a activity, in turn resulting from an increased expression of PLB-Ser16 and PLB-Thr17, to compensate for diastolic Ca 2ϩ leakage in ARKO LAs.
The APD and contraction of cardiomyocytes were sensitive to the external Ca 2ϩ concentration (37) . Elevated extracellular Ca 2ϩ increased the amplitudes of contractions in intact cardiac muscle and amplitudes of the LTCC and contraction in isolated myocyte models (38, 39) . In our study, the lower protein expression of Cav1.2 in ARKO LAs might account for poor contractility in response to changes in extracellular Ca 2ϩ . The mechanism of shortening of the cardiac AP by raising the extracellular Ca 2ϩ level has been proposed by the changes in NCX activity (40) . Upon incubation with a hypercalcemic solution, the higher NCX current in ARKO LAs might work in reverse mode and generate less inward current, which could explain why the APD was shortened in ARKO LAs but not in WT LAs on exposure to hypercalcemic solutions. In contrast, in the presence of hypocalcemic solutions, the NCX in ARKO LAs would work in the forward mode and generate more inward current, resulting in a higher DAD amplitude. Conversely, the hypercalcemic solutions had no effect on the genesis of DADs in either ARKO or WT LAs. Ouabain was known to increase intracellular Ca 2ϩ with enhancement of NCX currents through the inhibition of the Na ϩ /K ϩ -ATPase (41) . In this study, ouabain was found to induce larger amplitudes of the DADs in ARKO LAs but not in WT LAs. Therefore, ouabain might induce a greater Ca 2ϩ overload to cause DADs through the increased expression of NCX in ARKO LAs.
Based on our findings in this study, we propose essential roles for the up-regulated GRK2 and CaMKII in Ca 2ϩ dysregulation and the subsequent arrhythmogenesis in ARKO mice (Figure 8 ). Up-regulated GRK2 phosphorylated isoproterenol-bound receptors, leading to ␤-arrestin recruitment and acting as a scaffold for CaMKII and exchange protein activated by cAMP. Activated exchange protein activated by cAMP led to CaMKII activation via a Rap-phospholipase C⑀-protein kinase C⑀ mechanism and the subsequent hyperphosphorylation of the LTCC, RyR, and PLB, which in turn impaired cardiac functions and caused a predisposition to afterdepolarizations. Hyperphosphorylation of PLB-Ser16 by PKA and PLB-Thr17 by CaMKII, respectively, could enhance SR Ca 2ϩ uptake and might promote SR Ca 2ϩ overload. Furthermore, hyperphosphorylation of the LTCC resulted in increased Ltype Ca 2ϩ current which could predispose to EADs. Finally, hyperphosphorylation of the RyR resulted in SR Ca 2ϩ leakage that could result in DADs. Therefore, ARKO altered the atrial electrophysiology with up-regulated GRK2 and CaMKII, which resulted in arrhythmogenesis.
Taken together, our findings strongly support the hypothesis that ARKO changes the atrial electrophysiology with increased atrial arrhythmogenesis, which may be caused by atrial dysfunction with changes to CaMKII, GRK2, and channel proteins.
